MedPage Today on MSN
No benefit to surfactant in invasive mechanical ventilation for infant bronchiolitis
Endotracheal poractant alfa joins other interventions that lack clinical benefit ...
A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...
Bronchiolitis remains the leading cause of hospital admission in infancy and of paediatric intensive care unit use.1 Management of bronchiolitis has been largely limited to supportive care, reflecting ...
Researchers conducted a meta-analysis of 12 randomized controlled trials involving 2428 premature infants, comparing intratracheal budesonide plus pulmonary surfactant with pulmonary surfactant alone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results